Stage III Grade 3 Follicular Lymphoma Completed Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003204Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaTreatment